Skip to content
Review Open access

From amyloid PET to plasma biomarkers: A multimodal imaging framework for early diagnosis and staging of Alzheimer's disease

Jul 2026 · Alzheimer's & Dementia · Vol 18 · 0 citations · 60 references
Medicine

Abstract

Alzheimer's disease (AD) is biologically defined by amyloid beta and tau pathology. Available biomarkers enable early diagnosis but differ in targets, accessibility, and utility. This review synthesizes evidence for plasma biomarkers, magnetic resonance imaging (MRI), and positron emission tomography (PET) to develop a pragmatic, stage‐aware framework for early diagnosis and staging.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.